Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 89,326 shares at $64.42 ($5.8M) on 2020-06-11, disclosed to the SEC on 2022-02-11.
Open-market sale of $5.8M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.42 | 11,706 | $754K | 13.0% |
| 2 | $64.42 | 11,706 | $754K | 13.0% |
| 3 | $64.71 | 13,333 | $863K | 14.8% |
| 4 | $64.71 | 13,333 | $863K | 14.8% |
| 5 | $65.55 | 12,580 | $825K | 14.2% |
| 6 | $66.01 | 13,334 |
| $880K |
| 15.1% |
| 7 | $66.01 | 13,334 | $880K | 15.1% |
| Total | $65.14 avg | 89,326 | $5.8M | 100% |
| Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |
| BHVN | SELL | 2020-06-17 | $7.3M | — | Filing → |